Template:Guillain-Barré syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(16 intermediate revisions by 8 users not shown)
Line 16: Line 16:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Guillain-Barré syndrome (patient information)|Patient Info]]
[[Guillain-Barré syndrome (patient information)|Patient Information]]
|-  
|-  
|-  
|-  
Line 29: Line 29:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Guillain-Barré syndrome historical perspective|Historical perspective]]
[[Guillain-Barré syndrome historical perspective|Historical Perspective]]
|-  
|-  
!
!


|- bgcolor="Pink"
!
[[Guillain-Barré syndrome classification|Classification]]
|-
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Line 41: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Guillain-Barré syndrome epidemiology and demographics|Epidemiology & Demographics]]
[[Guillain-Barré syndrome causes|Causes]]
|-  
|-  
!
!
Line 47: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Guillain-Barré syndrome risk factors|Risk Factors]]
[[Differentiating Guillain-Barré syndrome from other diseases|Differentiating Guillain-Barré syndrome from other Diseases]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Guillain-Barré syndrome natural history, complications, and prognosis|Natural history, Complications, and Prognosis]]
[[Guillain-Barré syndrome epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 59: Line 63:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Guillain-Barré syndrome classification|Classification]]
[[Guillain-Barré syndrome risk factors|Risk Factors]]
|-  
|-  
!
!
Line 65: Line 69:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Guillain-Barré syndrome causes|Causes of Guillain-Barré syndrome]]
[[Guillain-Barré syndrome screening|Screening]]
|-  
|-  
!
!
Line 71: Line 75:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Guillain-Barré syndrome differential diagnosis|Differentiating Guillain-Barré syndrome from other Diseases]]
[[Guillain-Barré syndrome natural history, complications, and prognosis|Natural history, Complications, and Prognosis]]
|-  
|-  
!
!
Line 77: Line 81:
|- bgcolor="CornFlowerBlue"
|- bgcolor="CornFlowerBlue"
!
!
[[Guillain-Barré syndrome diagnosis | Diagnosis]]
Diagnosis
|-  
|-  
!
!
Line 83: Line 87:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Guillain-Barré syndrome history and symptoms|History & Symptoms]]
[[Guillain-Barré syndrome diagnostic study of choice|Diagnostic Study of Choice]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Guillain-Barré syndrome history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 95: Line 105:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Guillain-Barré syndrome laboratory tests|Lab Tests]]
[[Guillain-Barré syndrome laboratory tests|Laboratory Findings]]
|-  
|-  
!
!
Line 107: Line 117:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Guillain-Barré syndrome chest x ray|Chest X Ray]]
[[Guillain-Barré syndrome X-ray|X-ray]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Guillain-Barré syndrome Echocardiography and Ultrasound|Echocardiography and Ultrasound]]
|-  
|-  
!
!
Line 113: Line 129:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Guillain-Barré syndrome MRI|MRI]]
[[Guillain-Barré syndrome CT scan|CT scan]]
|-  
|-  
!
!
Line 119: Line 135:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Guillain-Barré syndrome CT|CT]]
[[Guillain-Barré syndrome MRI|MRI]]
|-  
|-  
!
!
Line 155: Line 171:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Guillain-Barré syndrome primary prevention|Primary Prevention]]
[[Guillain-Barré syndrome Primary prevention|Primary Prevention]]
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Guillain-Barré syndrome secondary prevention|Secondary Prevention]]
[[Guillain-Barré syndrome secondary prevention|Secondary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Guillain-Barré syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
|- bgcolor="PaleTurquoise"
!
[[Guillain-Barré syndrome future or investigational therapies|Future or Investigational Therapies]]
|-
!
|- bgcolor="CadetBlue"
!
Case Studies
|-
!
|- bgcolor="PaleTurquoise"
!
[[Guillain-Barré syndrome case study one|Case #1]]
|-
!


|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "

Latest revision as of 17:39, 20 December 2018